GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

W. P. Sheridan*, M. Wolf, J. Lusk, J. E. Layton, L. Souza, G. Morstyn, A. Dodds, D. Maher, M. D. Green, R. M. Fox

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Granulocyte colony-stimulating factor (G-CSF) was administered by continuous subcutaneous infusion to 15 patients with non-myeloid malignancies treated by high-dose chemotherapy and autologous bone marrow infusion. G-CSF was given at variable dosage based on neutrophil count. Sustained serum levels of G-CSF were achieved. Neutrophil recovery was accelerated in G-CSF treated patients compared with 18 historical controls and exceeded 0·5 × 109/l at a mean of 11 days after marrow infusion compared with 20 days for controls, a significant difference. This reduction led to significantly fewer days of parenteral antibiotic therapy, 11 versus 18 days in controls, and less isolation in reverse-barrier nursing, 10 versus 18 days.

Original languageEnglish
Pages (from-to)891-895
Number of pages5
JournalThe Lancet
Volume334
Issue number8668
DOIs
StatePublished - 14 Oct 1989
Externally publishedYes

Fingerprint

Dive into the research topics of 'GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION'. Together they form a unique fingerprint.

Cite this